M V25 (Hydrochlorothiazide and valsartan 25 mg / 320 mg)
Pill imprint M V25 has been identified as Hydrochlorothiazide and valsartan 25 mg / 320 mg.
Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 320 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M V25
- 25 mg / 320 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Blue No. 2
FD&C Yellow No. 6
sodium lauryl sulfate
More about hydrochlorothiazide/valsartan
- Hydrochlorothiazide and valsartan
- Valsartan and hydrochlorothiazide (Advanced Reading)
- Other brands: Diovan HCT
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.